Significance Of Multidrug Resistance Gene-Related Proteins In The Postoperative Chemotherapy Of Gastric Cancer

Pengfei Yu,Yian Du,Litao Yang,Sunfu Fan,Jian Wu,Shusen Zheng

2014-01-01

Abstract:Background: Multidrug resistance (MDR) is a serious problem in chemotherapy and is one of the main reasons for a poor outcome of gastric cancer. Study on the key proteins in multidrug resistance is necessary for the treatment of gastric cancer. Methods: The expression of ToPo II, MRP and GST-pi in 119 gastric cancers was retrospectively examined, and the results were analyzed in correlation with clinicopathological data. ToPo II negative, MRP positive and GST-pi positive were regarded as three risk factors which may be associated with chemotherapy resistance and poor prognosis. Patients were divided into two groups: high-risk group (>= 2 risk factors) and the low-risk group (<2 risk factors), and the tumor recurrence and patients' survival time of the two groups were also analyzed. Results: The positive rates of ToPo II, MRP and GST-pi were 73.9%, 42.9% and 51.3%, respectively. The positively correlation between the expression of MRP and GST-pi had been found. A significant correlation was shown between ToPo II expression and the level of differentiation. Significant differences with GST-pi expression were also found in relation to the sex and differentiation. In the high-risk group, the 3-year survival rate of patients with/without chemotherapy were 62.1% and 52.0%, 5-year survival rates were 44.8% and 40.0%, but the difference was not statistically significant (P>0.05). In the low-risk group, the 3-year survival rate of patients with/without chemotherapy were 81.2% and 51.5%, 5-year survival rates were 71.9% and 45.5%, and the difference was statistically significant (P<0.05). Conclusions: Combined detection of MDR-related proteins ToPo II, MRP and GST-pi may be prospectively valuable for postoperative individualized chemotherapy, and further predict the outcomes of gastric cancer patients.